THE WOODLANDS, Texas, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a business and pipeline update at the 44th Annual J.P. Morgan Healthcare Conference ...

THE WOODLANDS, Texas, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the publication of preclinical data validating Acyl-CoA Synthetase 5 (ACSL5) as a ...

Lexicon Pharmaceuticals Inc. (LXRX) reported its third-quarter 2025 earnings, showcasing a notable improvement in both revenue and earnings per share (EPS) compared to analyst expectations. The ...

THE WOODLANDS, Texas - Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), a $523 million market cap biotech company with a strong liquidity position, is moving forward with the 10 mg dose of its ...

Lexicon has pivoted back to a research-driven biotech model, abandoning internal drug marketing to focus on clinical development and out-licensing. Pilavapadin's upcoming Phase II readout is critical, ...

Lexicon Bank is excited to announce the expansion of its existing small business lending services to further assist small businesses in gaining access to capital through government-guaranteed lending ...

LEXICON SUPPORT SERVICES PRIVATE LIMITED is a Private Limited Company, governed by the Companies Act as a company limited by shares. Classified as a Non-government company, it is registered under the ...

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Lexicon Pharmaceuticals, Inc. before investing. In this article, we go over a few ...

Abstract: This hands-on tutorial teaches participants how to audit static analysis alerts, using an auditing lexicon and rules. There is no widely-accepted lexicon or standard set of rules for ...

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX) stock is trading higher on Friday. Penny stock Lexicon Pharmaceuticals entered into an exclusive license agreement with Novo Nordisk A/S (NYSE:NVO) on Friday ...